These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4429641)

  • 21. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 22. Subunit structure of fragment D from fibrinogen and cross-linked fibrin.
    Pizzo SV; Taylor LM; Schwartz ML; Hill RL; McKee PA
    J Biol Chem; 1973 Jul; 248(13):4584-90. PubMed ID: 4198060
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of fibrinogen and fibrin degradation products by isoelectric focusing in polyacrylamide gel.
    Arnesen H
    Thromb Res; 1974 Jun; 4(6):861-8. PubMed ID: 4844064
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.
    Mosher DF
    J Biol Chem; 1975 Aug; 250(16):6614-21. PubMed ID: 1158872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma.
    Wilhelm O; Hafter R; Henschen A; Schmitt M; Graeff H
    Blood; 1990 Apr; 75(8):1673-8. PubMed ID: 2139349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosslinking of soluble fibrin and fibrinogen.
    Selmayr E; Mahn I; Müller-Berghaus G
    Thromb Res; 1985 Aug; 39(4):467-74. PubMed ID: 2864751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibited thrombins. Interactions with fibrinogen and fibrin.
    Kaminski M; McDonagh J
    Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen).
    Greenberg CS; Enghild JJ; Mary A; Dobson JV; Achyuthan KE
    Biochem J; 1988 Dec; 256(3):1013-9. PubMed ID: 3066350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the thrombin clotting time. I. The influence of fibrinogen degradation products.
    Arnesen H; Godal HC
    Scand J Haematol; 1973; 10(3):232-40. PubMed ID: 4797626
    [No Abstract]   [Full Text] [Related]  

  • 31. On the location in the thrombin B chain of substrate recognition sites for fibrinopeptide release and factor XIII activation.
    Pirkle H; Theodor I; Christofferson M; Vukasin P; Miyada D
    Thromb Res; 1989 Sep; 55(6):737-46. PubMed ID: 2781534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin-dependent spleen transamidase.
    Zuch A
    Haemostasis; 1980; 9(2):85-91. PubMed ID: 6102074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of human des-AB fibrin and fibrinogen by sepharose-plasma chromatography at 20 degrees C and 37 degrees C.
    Mahn I; Krell W; Müller-Berghaus G
    Thromb Res; 1979; 14(4-5):651-63. PubMed ID: 483260
    [No Abstract]   [Full Text] [Related]  

  • 34. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro formation and i vivo clearance of fibrinogen: fibrin complexes.
    Sherman LA; Harwig S; Lee J
    J Lab Clin Med; 1975 Jul; 86(1):100-11. PubMed ID: 1151132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S; Yamada K
    Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gel filtration of 125I-fibrin and 131I-fibrinogen at 20 degrees C and 37 degrees C.
    Krell W; Mahn I; Müller-Berghaus G
    Thromb Res; 1979; 14(2-3):299-310. PubMed ID: 442008
    [No Abstract]   [Full Text] [Related]  

  • 39. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood coagulation factor XIII and fibrin stabilization (author's transl)].
    Rasche H
    Klin Wochenschr; 1975 Dec; 53(24):1137-45. PubMed ID: 765611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.